Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy.
Haydon
Rex C
RC
Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, Illinois 60637, USA.
Zhou
Lan
L
He
Tong-Chuan
TC
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001549:Benzamides; D002471:Cell Transformation, Neoplastic; D018890:Chemoprevention; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000517:prevention & control; D015195:Drug Design; D006801:Humans; D000068877:Imatinib Mesylate; D009369:Neoplasms / Q000188:drug therapy; D010879:Piperazines / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000494:pharmacology*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases